Rincon Pharmaceuticals Company
Rincon Pharmaceuticals develops and commercializes recombinant protein therapeutics such as monoclonal antibodies.
Employee Number:
11-50
Headquarters:
San Diego, California, United States
Technology:
Cancer
Estimated Revenue:
$1M to $10M
Founded Date:
2002
Industry:
PharmTech